Cavendish Financial Plc
Board Changes
19 DECEMBER 2023
Cavendish Financial plc announces that Mark Astaire has been appointed to its Board of Directors as an independent Non-Executive Director with effect from 1 January 2024.
Mark brings over 35 years of investment banking experience to the Board having held a number of senior leadership positions including Chairman of Corporate Broking at Barclays and Head of Corporate Broking at Bank of America Merrill Lynch. Mark was also a member of the Takeover Panel.
Mark is a member of the board of Sky News (which protects the editorial independence of Sky News), a Trustee of the charity Breast Cancer Now and a member of the International Advisory Board of the University of Edinburgh Business School.
Robert Lister, Deputy Chairman has informed us of his intention to step down from the Board of Directors on 31 December 2023 having led finnCap Group plc ("finnCap"), as Chairman, through its merger and subsequent integration with Cenkos Securities plc creating Cavendish Financial Plc in September 2023.
Commenting on today's announcement, Lisa Gordon, Chair said:
"I am delighted to welcome Mark to Cavendish and look forward to working with him. His appointment ensures that the Board has substantial and differential investment banking and client service experience as we continue to build on our strategic potential following our merger in September.
Robert - as Chairman - successfully led finnCap through a period of complex strategic and leadership change and was a tremendous partner in the creation of the new combined Group. On behalf of the Board, I would like to thank him for his significant contribution to the Board both pre-merger and during the integration of our businesses, which is now complete."
Commenting on his appointment, Mark Astaire said:
"Cavendish is a unique full-service investment bank focused on the small and mid-market, with the largest AIM client base and strong M&A franchises both in private and public company transactions.
I am very pleased to be joining the Board and look forward to working with Lisa and the wider Board, to deliver on Cavendish's potential."
Further information relating to Mark Astaire as required to be disclosed under the AIM Rules for Companies is set out below.
Contacts
Cavendish (Management) Tel: +44 (0) 20 7220 0500
Lisa Gordon, Chair investor.relations@cavendish.com
Julian Morse, Co-Chief Executive Officer
John Farrugia, Co-Chief Executive Officer
Ben Procter, Chief Financial Officer
Grant Thornton (Nominated Adviser) Tel: +44 (0) 20 7383 5100
Philip Secrett/Samantha Harrison/Ciara Donnelly
Cavendish (Broker) Tel: +44 (0) 20 7220 0500
Tim Redfern
Hudson Sandler (PR adviser) Tel: +44 (0) 20 7796 4133
Dan de Belder/Rebekah Chapman
The following information is disclosed in accordance with Rule 17 and paragraph (g) of Schedule 2 of the AIM Rules for Companies in connection with the appointment of Mark David Astaire, aged 64, to the Board of the Company:
| Current directorships The Wendover Foundation (Trustee of the Charity) Breast Cancer Now (Director and Trustee of the Charity) The Goodwinds II Trust (Protector) | Past directorships held within the last five years Breast Cancer Care (Director and Trustee of the Charity) The Takeover Panel |
| | |
Mark does not hold any legal or beneficial direct or indirect interest in the securities of the Company.
There are no other matters under paragraph (g) of Schedule 2 of the AIM Rules to be disclosed.
END
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
